| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/11/1994 | WO1994010292A1 Biological factors and neural stem cells |
| 05/11/1994 | WO1994010207A2 Truncated insulin-like growth factor binding proteins having mitogenic activity |
| 05/11/1994 | WO1994010206A1 Intrinsic inhibitors of aldose reductase |
| 05/11/1994 | WO1994010203A2 Op-3-induced morphogenesis |
| 05/11/1994 | WO1994010202A1 Vascular endothelial cell growth factor antagonists |
| 05/11/1994 | WO1994010201A1 Peptides and vaccines derived from nematode tubulin |
| 05/11/1994 | WO1994010200A1 Somatotropin modifications |
| 05/11/1994 | WO1994010199A1 Expression and purification of cloned human alpha-fetoprotein |
| 05/11/1994 | WO1994010198A1 Method of reducing multidrug resistance in cells and tissues |
| 05/11/1994 | WO1994010197A1 A novel protein tyrosine kinase |
| 05/11/1994 | WO1994010196A1 Calcium channel blocking polypeptides from theraphosidae aphonopelma |
| 05/11/1994 | WO1994010195A1 Calcium channel blocking polypeptides from heteropoda venatoria |
| 05/11/1994 | WO1994010194A2 Molecule fragments (peptides) of the main allergens contained in the pollen of trees of the fagales order |
| 05/11/1994 | WO1994010193A1 Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace |
| 05/11/1994 | WO1994010192A1 Process for manufacturing crystals of growth hormone and crystals thereby obtained |
| 05/11/1994 | WO1994010191A1 Low allergenic proteins |
| 05/11/1994 | WO1994010187A1 COMPOSITIONS AND METHODS FOR MODIFYING THE REGULATORY ACTIVITY OF TGF-$g(b) |
| 05/11/1994 | WO1994010172A1 Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof |
| 05/11/1994 | WO1994010149A1 Molecule labelling using 2-hydraninopyridine derivatives |
| 05/11/1994 | WO1994010137A1 Inhibitors of farnesyl-protein transferase |
| 05/11/1994 | WO1994010134A1 Hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors |
| 05/11/1994 | WO1994009828A1 Dna encoding a human serotonin receptor (5-ht4b) and uses thereof |
| 05/11/1994 | WO1994009825A1 DIAGNOSIS AND TREATMENT OF OSTEOARTHRITIS INVOLVING A 92 kD GELATINASE |
| 05/11/1994 | WO1994009823A1 Urease-based vaccine against helicobacter infection |
| 05/11/1994 | WO1994009820A1 Prostate-specific membrane antigen |
| 05/11/1994 | WO1994009818A1 Method for stimulating production of variable region gene family restricted antibodies through b-cell superantigen vaccination |
| 05/11/1994 | WO1994009816A1 Use of an enteric coated papain-containing food supplement for controlling auto immune diseases |
| 05/11/1994 | WO1994009815A1 USES OF TGF-β RECEPTOR FRAGMENT AS A THERAPEUTIC AGENT |
| 05/11/1994 | WO1994009813A1 Method for treatment or prevention of obesity |
| 05/11/1994 | WO1994009812A1 METHOD FOR PRODUCING LARGE LATENT TRANSFORMING GROWTH FACTOR-β COMPLEXES AND LARGE LATENCY ASSOCIATED PEPTIDE |
| 05/11/1994 | WO1994009811A1 An adhesion molecule |
| 05/11/1994 | WO1994009810A1 Novel biologically active peptides and uses therefor |
| 05/11/1994 | WO1994009809A1 Method for preventing or treating liver disease |
| 05/11/1994 | WO1994009808A1 Substances having the growth-promoting effect of amyloid precursor protein |
| 05/11/1994 | WO1994009807A1 Pharmaceutical preparations containing neurotrophic factors and gangliosides for treating nervous system pathologies |
| 05/11/1994 | WO1994009806A1 Preparation for therapeutic and especially prophylactic treatment of digestive tract disorders |
| 05/11/1994 | WO1994009805A2 Method of treating recurrent miscarriage and improving the efficacy of assisted reproductive techniques using placental protein 14 |
| 05/11/1994 | WO1994009804A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 05/11/1994 | WO1994009803A1 Enhancement of xenograft tolerance and porcine cytokines therefor |
| 05/11/1994 | WO1994009802A1 Novel bowman-birk inhibitor product for use as an anticarcinogenesis agent |
| 05/11/1994 | WO1994009793A1 ENANTIOMERICALLY PURE β-D-DIOXOLANE NUCLEOSIDES WITH SELECTIVE ANTI-HEPATITIS B VIRUS ACTIVITY |
| 05/11/1994 | WO1994009792A1 Small molecule inhibition of rna/ligand binding |
| 05/11/1994 | WO1994009765A1 Functional interactions between glial s-100b and central nervous system serotonergic neurons |
| 05/11/1994 | WO1994009651A1 Anti-diarrheic product and method of treating rotavirus-associated infection |
| 05/11/1994 | WO1993024641A3 Adeno-associated virus with inverted terminal repeat sequences as promoter |
| 05/11/1994 | EP0596675A1 Artificial saliva compositions |
| 05/11/1994 | EP0596459A2 Process for purifying recombinant proteins, and use of products thereof |
| 05/11/1994 | EP0596355A1 Method for the assay of enkephalinase |
| 05/11/1994 | EP0596350A1 Cyclopeptides |
| 05/11/1994 | EP0596034A1 Purification of recombinant ciliary neurotrophic factor and c-terminal truncated ciliary neurotrophic factor and methods for treating peripheral nerve damage |
| 05/11/1994 | EP0596031A1 Neural calcium-activated neutral proteinase inhibitors |
| 05/11/1994 | EP0596026A1 Antibiotic feed compositions and method of enhancing feed efficiency and promoting growth in monogastic animals |
| 05/11/1994 | EP0596024A1 Lipid conjugates of therapeutic peptides and protease inhibitors |
| 05/11/1994 | EP0596011A1 Trifunctional compounds having specificity for multi-drug resistant cells |
| 05/11/1994 | EP0595920A1 Bacterial esterase for cocaine detection |
| 05/11/1994 | EP0595878A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use |
| 05/11/1994 | EP0595873A1 Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 05/11/1994 | EP0595863A1 Implant materials |
| 05/11/1994 | EP0595855A1 Allergenic proteins and peptides from japanese cedar pollen |
| 05/11/1994 | EP0595838A1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 05/11/1994 | EP0595822A1 Thyroidal receptor for n-acetylglucosamine |
| 05/11/1994 | EP0558671A4 Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures |
| 05/11/1994 | EP0489771B1 MODIFIED HUMAN ANTI-Rh(D) ANTIBODIES |
| 05/11/1994 | EP0344297B1 Treatment of cancer with somatostatin and analogs thereof |
| 05/11/1994 | DE4237668A1 DNA encoding aphrodisin with an N-terminal signal peptide |
| 05/11/1994 | DE4237502A1 Medicaments contg. anti-idiotype-CD14 antibodies - having high endotoxin binding capacity, used for treating e.g. infections, burns, ARDS, septic shock or psoriasis |
| 05/11/1994 | CN1086543A CDNA clones coding for polypepstides exhibiting human granulocyte macrophage and eosinophie cellular growth |
| 05/11/1994 | CN1086437A Method for inhibiting HIV replication using IL-4 |
| 05/11/1994 | CA2148685A1 Truncated insulin-like growth factor binding proteins having mitogenic activity |
| 05/11/1994 | CA2148504A1 Calcium channel blocking polypeptides from theraphosidae aphonopelma |
| 05/11/1994 | CA2148479A1 Fibronectin binding protein as well as its preparation |
| 05/11/1994 | CA2148368A1 Tnf-.alpha. ribozymes and degradation resistant mrna derivatives linked to tnf-.alpha. ribozymes |
| 05/11/1994 | CA2148261A1 Anti-diarrheic product and method of treating rotavirus-associated infection |
| 05/11/1994 | CA2148255A1 Preparation for therapeutic and especially prophylactic treatment of digestive tract disorders |
| 05/11/1994 | CA2148244A1 Angiogenesis inhibitory antibodies |
| 05/11/1994 | CA2148119A1 Interferon tau compositions and methods of use |
| 05/11/1994 | CA2147769A1 Novel biologically active peptides and uses therefor |
| 05/11/1994 | CA2147756A1 Peptides and vaccines derived from nematode tubulin |
| 05/11/1994 | CA2147754A1 Compositions and methods for modifying the regulatory activity of tgf- .beta. |
| 05/11/1994 | CA2147741A1 Low allergenic proteins |
| 05/11/1994 | CA2147605A1 Small molecule inhibition of rna/ligand binding |
| 05/11/1994 | CA2147598A1 Op-3-induced morphogenesis |
| 05/11/1994 | CA2147509A1 Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof |
| 05/11/1994 | CA2147494A1 Intrinsic inhibitors of aldose reductase |
| 05/11/1994 | CA2147359A1 Method and device for reconstruction of articular cartilage |
| 05/11/1994 | CA2147286A1 Inhebitors of farnesyl-protein transferase |
| 05/11/1994 | CA2146559A1 Methods of preparing soluble, oligomeric proteins |
| 05/11/1994 | CA2145546A1 Somatotropin modifications |
| 05/11/1994 | CA2143489A1 Transformed endothelial cells |
| 05/11/1994 | CA2142997A1 Hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors |
| 05/11/1994 | CA2127283A1 Urease-based vaccine against helicobacter infection |
| 05/11/1994 | CA2124694A1 Method of treating recurrent miscarriage and improving the efficacy of assisted reproductive techniques using placental protein 14 |
| 05/11/1994 | CA2120131A1 Expression and purification of cloned human alpha-fetoprotein |
| 05/10/1994 | US5310958 Durg delivery, side effect reduction |
| 05/10/1994 | US5310883 Stabilized versions of glu-3,5-basic FGF having eliminated disulfide scrambled forms; wound healing agents; promoters of angiogenesis, neutrotropism and chemotaxis |
| 05/10/1994 | US5310881 Reaction product of mucopolysaccharides and enzymes, sustained release, drugs |
| 05/10/1994 | US5310880 Purification of Mullerian inhibiting substance |
| 05/10/1994 | US5310879 For gramnegative bacteria assay |
| 05/10/1994 | US5310875 Antiallergens |
| 05/10/1994 | US5310873 Cyclohexapeptide compound |